Cobra Biologics, an international CDMO of biologics and pharmaceuticals, has been recognised with a CMO Leadership Award 2017 in the the first five out of the six total categories: Quality, Reliability, Capabilities, Expertise, Compatibility and Development.
The awards were organised by Life Science Leader magazine and recipients determined through customer feedback collected by Industry Standard Research (ISR).
This year’s research included survey responses from more than 339 biopharma and pharma professionals who use contract development and manufacturing services.
More than 80 contract manufactures were assessed by 26 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking survey.
Survey participants were recruited from pharma and biopharma companies of all sizes and were screened for decision-making influence related to working with contract manufacturing suppliers.
Respondents only evaluate companies with which they have worked on an outsourced project within the past 18 months ensuring that survey responses are based on actual involvement with contract manufacturers and clear experiential data.
The awards were presented at a reception dinner at The W Hotel in New York City, USA.